In this study, we had collected 300 probands with RP in an outpatient setting. In the follow-up genetic study, we identified eight mutations in the RHO gene that is responsible for the disease.
METHODS
Patients and clinical data: 300 probands enrolled in this study were come maily from Hebei Province, Henan province and Shanxi province. Probands include 171 males and 129 females. Patients come to our hospital from ages 5 to 72 years. After probands were diagnosed RP, their family history inquiry were collected in detail and their family members were recruited further. The probands enrolled in this study were from Hebei Province, China. Clinical examination, peripheral blood collection, and DNA extraction were performed at the Department of Ophthalmology, Hebei Ophthalmic Hospital. Peripheral blood was drawn after register and preserved at -80 °C Ultra-low temperature freezer prior to use. Genomic DNA was isolated with DNA extraction kit (DP332, Tiangen, Beijing, China). Informed consent was obtained from all participants in accordance with the Declaration of Helsinki, the Institutional Review Board, and Ethics Committee of Hebei Province. Clinical data for the subjects were ascertained with detailed ocular examinations. In addition, physical examinations were performed to exclude systemic diseases.
In the mutation analysis, coding exons of RHO were amplified with PCR using a set pair of primers [8] . The PCR products were sequenced on an ABI3730 Automated Sequencer (PE Biosystems, Foster City, CA). Briefly, PCR amplification conditions were: Reaction Mixture Set Up (50 μl); 2 μl (40 ng/ml) of DNA, 1.5 μl (10 pM) of each exon primer, 20 μl of water, and 25 μl of PCR mix (2× EasyTaq PCR SuperMix, TransGen, Beijing, China) in a final reaction volume of 50 μl. Thermal cycling conditions were: an initial denaturation step at 95 °C for 5 min, 36 cycles (30 s at 95 °C, 30 s at 58 °C, and 30 s at 72 °C) and a final 10 min 72 °C extension. The PCR products were sequenced on an ABI3730 automated sequencer (PE Biosystems, Foster City, CA).
RESULTS

Clinical findings:
All probands showed typical RP disease ( Table 1 ). The 300 probands included 40 with adRP, 38 with autosomal recessive RP (arRP), and 222 sporadic cases. The physical examinations excluded systemic disorders in all patients.
Mutation analysis: Sequence analysis of the coding region of RHO was performed in the probands. Eight heterozygous nucleotide changes were detected in eight of the 300 probands with RP ( Figure 1, Figure 2 ). p.R21C, p.C110S, p.G182V, p.C187G, c.409-426delGTGGTGGTGTGTAAGCCC, and p.P347L were found in six autosomal dominant families. p.T92I and p.Y178C were found in two isolated cases. The eight mutations include six novel mutations (p.R21C, p.T92I, p.C110S, p.G182V, p.C187G, and c.409-426delGTGGTG-GTGTGTAAGCCC) and two known mutations (p.Y178C and p.P347L). Of the eight mutations, seven were missense changes, and one was a small deletion ( Figure 3 ). Missense mutations were predicted to be pathogenic with SIFT and Polyphen-2 prediction software ( Table 2 ). These mutations were not found in 100 control individuals from the same ethnic background. The mutation frequencies were 15% (6/40) for adRP, 0.9% (2/222) for sporadic RP, and 2.7% (8/300) in total. No mutation was detected in families with arRP.
DISCUSSION
In this study, 300 families with RP in an outpatient setting in the past 2 years were collected consecutively. In the follow-up genetic study, we identified eight mutations in the RHO gene. The results show that RHO mutations accounted for a high proportion (15%, 6/40) in Chinese patients with adRP. RHO mutations in arRP and sporadic RP are not common.
Up to now, more than 160 mutations of RHO have been found in different racial and ethnic populations (HGMD). Studies show that mutations in this gene are responsible for approximately 25% of adRP in American patients. The P23H mutation occurs most frequently in American patients but has not been reported in patients with RP in other ethnic populations [6, 10] . P347L and Y178C mutations have been reported in several ethnic populations [6, [8] [9] [10] [11] [12] [13] .
The proportion of RHO mutations in Asia is lower than in the United States and Europe. The proportion of RHO mutations in Chinese patients was 2.0-5.6%, 2.0% in Koreans, 2.0% in Japanese, and 2.0% in Indians [8] [9] [10] 14] .
In conclusion, our study provides useful material for evaluating the proportion of RHO mutations in Chinese patients with RP. We revealed the spectrum and frequency of RHO mutations in Chinese patients with RP. RHO mutations were found in 2.7% of the Chinese patients.
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